Abnormal incorporation of arachidonic acid into platelets of drug-free patients with schizophrenia

Psychiatry Research

Volumn 60, Issue 1, 1996, Pages 11-21

  Yao, Jeffrey K ^a   Van Kammen, Daniel P ^a   Gurklis, John A ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Diacylglycerol; Eicosanoids; Haloperidol; Second messengers

Indexed keywords

ARACHIDONIC ACID; DIACYLGLYCEROL; HALOPERIDOL; ICOSANOID; PHOSPHOLIPID; THROMBIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG WITHDRAWAL; HUMAN; HUMAN EXPERIMENT; MALE; PRIORITY JOURNAL; SCHIZOPHRENIA; THROMBOCYTE;

EID: 0029912949     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/0165-1781(95)02832-3     Document Type: Article

References (57)

1. American Psychiatric Association. (1987) DSM-III-R: Diagnostic and Statistical Manual of Mental Disorders. 3rd rev. edn. American Psychiatric Press, Washington, DC.
2. Andreasen, N.C. (1982) Negative symptoms in schizophrenia: definition and reliability. Arch Gen Psychiatry 39, 784-794.
3. Avdonin, P.V., Cheglakov, I.B., Boogry, E.M., Svitina-Ultina, I.V., Mazaev, A.V. and Tkachuk, V.A. (1987) Evidence for the receptor-operated calcium channels. Thromb Res 46, 29-37.
4. Baraban, J.M., Worley, P.F. and Snyder, S.H. (1989) Second messenger psychoactive drug action: focus on the phosphoinositide system and lithium. Am J Psychiatry 146, 1251-1260.
5. Billah, M.M., Lapetina, E.G. and Cuatrecasas, P. (1979) Phosphatidylinositol-specific phospholipase C of platelets: association with 1,2-diacylglycerol-kinase and inhibition by cyclic AMP. Biochem Biophys Res Commun 90, 92-98.
6. Bowden, C.L., Huang, L.G., Javors, M.A., Johnson, J.M., Seleshi, E., McIntyre, K., Contreras, S. and Maas, J.W. (1988) Calcium function in affective disorders and healthy controls. Biol Psychiatry 23, 367-376.
7. Bunney, W.E., Jr., and Hamburg, D.A. (1963) Methods for reliable longitudinal observation of behavior. Arch Gen Psychiatry 9, 280-294.
8. Carlton, P. L. and Manowitz, P. (1984) Dopamine and schizophrenia: an analysis of the theory. Neurosci Behav Rev 8, 137-151.
9. 2 receptor site. J Biol Chem 260, 7603-7608.
10. 1-like dopamine receptors on human platelets. Life Sci 42, 1797-1806.
11. DeLisi, L.E. (1987) Viral and immunologic hypotheses for schizophrenia. In: Meltzer, H.Y. (Ed.), Psychopharmacology: The Third Generation of Progress. Raven Press, New York, pp. 765-771,
12. 14C-arachidonic acid into platelet phospholipids of untreated patients with schizophreniform or schizophrenic disorders. Psychiatry Res 22, 275-282.
13. Demisch, L., Heinz, K., Gerbaldo, H. and Kirsten, R. (1992) Increased concentrations of phosphatidylinositol (PI) and decreased esterification of arachidonic acid into phospholipids in platelets from patients with schizoaffective disorders or atypic phasic psychoses. Prostaglandins Leukot Essent Fatty Acids 46, 47.
14. Doyle, V.M. and Ruegg, U.R. (1985) Lack of evidence for voltage dependent calcium channels on platelets. Biochem Biophys Res Commun 127, 161-167.
15. Endicott, J. and Spitzer, R.L. (1978) A diagnostic interview: the Schedule for Affective Disorders and Schizophrenia. Arch Gen Psychiatry 35, 837-844.
16. Erne, P., Bolli, P., Burgisser, E. and Buhler, F.R. (1984) Correlation of platelet calcium with blood pressure: effect of antihypertensive therapy. N Engl J Med 310, 1084-1088.
17. Essali, M.A., Das, I., de Belleroche, J. and Hirsch, S.R. (1990) The platelet polyphospho-inositide system in schizophrenia: the effects of neuroleptic treatment. Biol Psychiatry 28, 475-487.
18. Hallam, T.H., Thompson, N.T., Serutton, M.C. and Rink, T.J. (1984) The role of cytoplasmic free calcium in the responses of Quin2 loaded human platelets to vasopressin. Biochem J 221, 897-901.
19. Joyce, J.N., Shane, A., Lexow, M.S., Winokur, A., Casanova, M. and Kleinman, J.E. (1993) Serotonin uptake sites and serotonin receptors are altered in the limbic system of schizophrenics. Neuropsychopharmacology 8, 315-336.
20. Kaiya, H., Nishida, A., Imai, A., Nakashima, S. and Nozawa, Y. (1989) Accumulation of diacylglycerol in platelet phosphoinositide turnover in schizophrenia: a biological marker of good prognosis? Biol Psychiatry 26, 669-676.
21. Lachman, H.M. and Papolos, D.F. (1989) Abnormal signal transduction: a hypothetical model for bipolar affective disorder. Life Sci 45, 1413-1426.
22. Lands, W.F.M. and Crawford, C.G. (1976) Enzymes of membrane phospholipid metabolism in animals. In: Martonosi, A., (Ed.), The Enzymes of Biological Membranes. John Wiley and Sons, New York, p. 3.
23. Lapetina, E.G. (1990) The signal transduction induced by thrombin in human platelets. FEBS Lett 268(2), 400-404.
24. Lapetina, E.G. and Cuatrecasas, P. (1979) Stimulation of phosphatidic acid production in platelets precedes the formation of arachidonate and parallels the release of serotonin. Biochim Biophys Acta 573, 394-402.
25. Lapetina, E.G. and Hawthorne, J.N. (1971) The diglyceride kinase of rat cerebral cortex. Biochemistry 122, 171-179.
26. Laychock, S.G. and Putney, J.W., Jr. (1982) Role of phospholipid metabolism in secretory cells. In: Conn, M. (Ed.), Cellular Regulation of Secretion and Release. Academic Press, New York, p. 53.
27. Lieberman, J.A. and Koreen, A.R. (1993) Neurochemistry and neuroendocrinology of schizophrenia: a selective review. Schizophr Bull 19, 371-429.
28. Liscovitch, M. (1991) Signal-dependent activation of phosphatidylcholine hydrolysis: role of phospholipase D. Biochem Soc Trans 19, 402-407.
29. Liscovitch, M. (1992) Crosstalk among multiple signal-activated phospholipases. Trends Biochem Sci 17, 393-399.
30. Malenka, R.C., Hamblin, M.W. and Barchas, J.D. (1989) Biochemical hypotheses of affective disorders and anxiety. In: Siegel, G.J., Agranoff, B.W., Albers, R.W. and Molinoff, P.B. (Eds.), Basic Neurochemistry: Molecular, Cellular, and Medical Aspects. 4th edn. Raven Press, New York, pp. 877-891.
31. Meltzer, H.Y. (1987) Biological studies in schizophrenia. Schizophr Bull 13, 77-111.
32. Meltzer, H.Y. (1989) Clinical studies on the mechanism of action of clozapine: the dopamine-serotonin hypothesis of schizophrenia. Psychopharmacology 99, S18-S27.
33. Nishizuka, Y. (1986) Studies and perspectives of protein kinase C. Science 233, 305-312.
34. Nishizuka, Y. (1992) Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science 258, 607-614.
35. 2+-transporting membrane vesicle fraction derived from human platelets. J Biol Chem 260, 956-962.
36. Overall, J.E. and Gorham, D.R. (1962) The Brief Psychiatric Rating Scale. Psychol Rep 10, 799-812.
37. Passenon, M.K. (1968) Platelet 5-hydroxytryptamine as a model in pharmacology. Annales Medicanae Experimentalis et Biologiae Fenniae 46, 416-422.
38. 3H-imipramine binding label serotonin reuptake sites in brain and platelet? Life Sci 28, 2753-2760.
39. Pletscher, A. (1978) Platelets as models for monographic neurons. In: Youdim, M.B.H., Lovenberg, W., Sharman, D.F. and Lagnado, J.R. (Eds.), Essays in Neurochemistry and Neuropharmacology. Vol. 13. John Wiley and Sons, New York, p. 48.
40. Pletscher, A. (1981) Liberation of catecholamines from blood platelets. Br J Pharmacol 72, 349-354.
41. Rittenhouse-Simmons, S. (1979) Production of diglyceride from phosphatidylinositol in activated human platelets. Clin Invest 63, 580-587.
42. Rotrosen, J. and Wolkin, A. (1987) Phospholipid and prostaglandin hypotheses of schizophrenia. In: Meltzer, H.Y. (Ed.), Psychopharmacology: The Third Generation of Progress. Raven Press, New York, pp. 759-764.
43. 2+]irises evoked by thrombin and PAF in human platelets. Eur J Pharmacol 128, 99-107.
44. 3H-spiperone binding in platelet membrane: a possible biological marker for schizophrenia. Acta Psychiatr Scand 73, 186-190.
45. Siess, W., Cuatrecasas, P. and Lapetina, E.G. (1983) A role for cyclo-oxygenase products in the formation of phosphatidic acid in stimulated human platelets. J Biol Chem 258, 4683-4686.
46. Sneddon, J.M. (1973) Blood platelets as a model for monoamine-containing neurons. Prog Neurobiol 1, 151-198.
47. Stahl, S.M. (1977) The human platelet: a diagnostic and research tool for the study of biogenic amines in psychiatric and neurologic disorders. Arch Gen Psychiatry 34, 509-516.
48. Tandon R. and Greden, J.F. (1989) Cholinergic hyperactivity and negative schizophrenic symptoms: a model of dopaminergic/cholinergic interactions in schizophrenia. Arch Gen Psychiatry 46, 745-753.
49. van Kammen, D.P. and Kelley, M. (1991) Dopamine and norepinephrine activity in schizophrenia: an integrative perspective. Schizophr Res 4, 173-191.
50. van Kammen, D.P., Peters, J., van Kammen, W.B., Nugent, A., Goetz, K. L., Yao, J. and Linnoila, M. (1989) Elevated CSF NE and relapse in schizophrenia. Biol Psychiatry 26, 178-188.
51. Vargas, J.R., Radomski, M. and Moncada, S (1982) The use of prostacyclin in the separation from plasma and washing of human platelets. Prostaglandins 23, 929-945.
52. Watson, S.P., McConnell, R.T. and Lapetina, E.G. (1984) The rapid formation of inositol phosphates in human platelets by thrombin is inhibited by prostacyclin. J Biol Chem 259, 13199-13202.
53. Yao, J.K. and Rastetter, G.M. (1985) Microanalysis of complex lipids by high-performance thin-layer chromatography. Anal Biochem 150, 111-116.
54. Yao, J.K. and van Kammen, D.P. (1994) Red blood cell membrane dynamics in schizophrenia. I. Membrane fluidity. Schizophr Res 11,209-216.
55. Yao, J.K., van Kammen, D.P. and Welker, J.A. (1994) Red blood cell membrane dynamics in schizophrenia. II. Fatty acid composition. Schizophr Res 13, 217-226.
56. Yao, J.K., Yasaei, P. and van Kammen, D.P. (1992) Increased turnover of platelet phosphatidyl-inositol in schizophrenia. Prostaglandins Leukot Essent Fatty Acids 46, 39-46.
57. Young, W.E. (1986) Human monoamine oxidase: lack of brain and platelet correlation. Arch Gen Psychiatry 43, 604-609.